Buradasınız

PREVENTION OF DIABETIC CARDIOMYOPATHY BY A NOVEL PROTEIN OF EUGENIA JAMBOLANA SEEDS ON STREPTOZOTOCIN INDUCED DIABETES IN RATS.

Journal Name:

Publication Year:

Abstract (2. Language): 
In the present study the antioxidant effect of oral administration of purified protein from ethanolic extract of Eugenia Jambolana seed kernel on protective effect of streptozotocin-induced diabetic rats was evaluated. Administration of a novel protein to diabetic rats significantly decreased the levels of blood glucose, glycosylated hemoglobin and increased body weight gain and biochemical parameters. The diabetic rats showed the low activities of glutathione peroxides and reduced glutathione content heart tissues which were restored to near normal levels by experimental treatment with protein of Eugenia Jambolana. The increased levels of lipid peroxidation and hydroperoxides in diabetic rats were reverted back to near normal levels after the treatment and restored almost normal microarchitecture of heart which was confirmed by histopathological examination. The present study reveals the efficacy of Eugenia Jambolana seed kernel in the amelioration of diabetes cardiomyopathy which may be attributed to its hypoglycemic property along with its antioxidant potential.
526
530

REFERENCES

References: 

1. E. L. Barr, P. Z. Zimmet, T. A. Welborn, D. Jolley, and
D. J. Magliano. Risk of cardiovascular and all-cause
mortality in individuals with diabetes mellitus,
impaired fasting glucose, and impaired glucose
tolerance: the Australian Diabetes, Obesity, and
Lifestyle Study (AusDiab), Circulation 116: 151-157
(2007).
2. A. G. Bertoni, A. Tsai, E. K. Kasper, and F. L. Brancati.
Diabetes and idiopathic cardiomyopathy: a
nationwide case-control study, Diabetes Care 26:
2791- 2795 (2003).
3. B. K. William, H. Marthana, and P. C. William. Role of
diabetes in congestive heart failure: The
Framingham Study, Am J Cardiol., 34: 29-34 (1974).
4. Y. Kohda, T. Tanaka, H. Matsumura. Effects of
Thiamine Repletion on Cardiac Fibrosis and Protein
O-Glycosylation in Diabetic Cardiomyopathy, J
Diabetes Metabolism S7:001. doi:10.4172/2155-
6156.S7-001 Page ISSN: 2155-6156 (2012).
5. S. K. Mukherjee, L. K. Klaidman, R. Yasharel, J. D.
Adams. Increased brain NAD prevents neuronal
apoptosis in vivo, Eur J Pharmacol., 330: (1) 27-34
(1997).
6. J. P. Piccini, L. Klein, M. Gheorghiade, and R. O.
Bonow. New insights into diastolic heart failure:
role of diabetes mellitus, Am J Med., 116: 64S-75S
(2004).
7. M. A. Weber, G. L. Bakris, K. Jamerson, M. Weir, and
S. E. Kjeldsen. Cardiovascular events during
differing hypertension therapies in patients with
diabetes, J Am Coll Cardiol., 56: 77-85 (2010).
8. N. Sekar, S. Kanthasamy, S. William, S. Subramanian,
and S. Govindasamy. Insulinic actions of vanadate in
diabetic rats, Pharmacol. Res,. 22: 207-217 (1990).
9. R. Burcelin, M. Eddouksm, J. Maury, J. Kande, R.
Assan, J. Girard. Excessive glucose production,
rather than Insulin resistance, accountfor
hyperglycemia in recent onset streptozocin-diabetic
rats, Diabetologia 35: 283-290 (1995).
10. A. Relander, C. E. Raiha. Differences between the
enzymatic and toluidine methods of blood glucose
determination, Scandinavian Journal of Clinical and
Laboratory Investigation 15: 221–224 (1963).
11. J. Sed gb’]-+lak, R. H. Linday. Estimation of total
protein bound and non protein sulhydryl groups in
tissue with Ellman’s reagents, Analytical
Biochemistry 25: 192-205 (1968).
12. O. H. Lowry, N. H. Rosebrough, A. L. Farr and R. J.
Randal. Protein measurement with the Folin phenol
reagent, J. Biol. Chem., 193: 256-275 (1951).
13. D. Braham and P.Tinder. An improved color reagent
for the determination of blood glucose by the
oxidase system, Analyst 97: 142-45 (1972).

Thank you for copying data from http://www.arastirmax.com